THE USE OF LOW MOLECULAR WEIGHT DEXTRAN IN EXTRACORPOREAL CIRCULATION.

N. Martinović,D. Melrose

1963-08-01

Abstract:

What problem does this paper attempt to address?

Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects

Qing-Yu Zhang,Fei-Xuan Wang,Ke-Ke Jia,Ling-Dong Kong

DOI: https://doi.org/10.3389/fphar.2018.01253

IF: 5.6

2018-01-01

Frontiers in Pharmacology

Abstract:Cancer is the second leading cause of death in the world. Chemotherapy and radiotherapy are the common cancer treatments. However, the development of adverse effects resulting from chemotherapy and radiotherapy hinders the clinical use, and negatively reduces the quality of life in cancer patients. Natural products including crude extracts, bioactive components-enriched fractions and pure compounds prepared from herbs as well as herbal formulas have been proved to prevent and treat cancer. Of significant interest, some natural products can reduce chemotherapy and radiotherapy-induced oral mucositis, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, hematopoietic system injury, cardiotoxicity, and neurotoxicity. This review focuses in detail on the effectiveness of these natural products, and describes the possible mechanisms of the actions in reducing chemotherapy and radiotherapy-induced side effects. Recent advances in the efficacy of natural dietary supplements to counteract these side effects are highlighted. In addition, we draw particular attention to gut microbiotan in the context of prebiotic potential of natural products for the protection against cancer therapy-induced toxicities. We conclude that some natural products are potential therapeutic perspective for the prevention and treatment of chemotherapy and radiotherapy-induced side effects. Further studies are required to validate the efficacy of natural products in cancer patients, and elucidate potential underlying mechanisms.
Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review

Christine Yen,Fan Zhao,Zhichao Yu,Xiaoshu Zhu,Chun Guang Li

DOI: https://doi.org/10.3389/fphar.2022.847113

IF: 5.6

2022-06-03

Frontiers in Pharmacology

Abstract:Introduction: Tamoxifen (TAM) is the most commonly used hormone therapeutic drug for the treatment of estrogen receptor-positive (ER+) breast cancer. 30%–70% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions. Objective: To evaluate the evidence for the interactions between natural products and TAM in breast cancer. Methods: Electronic databases, including PubMed, CINAHL Plus ( via EbscoHost), European PMC, Medline, and Google Scholar, were searched for relevant publications. The search terms include complementary and alternative medicine, natural products, plant products, herbs, interactions, tamoxifen, breast cancer, and their combinations. Results: Various in vitro and in vivo studies demonstrated that the combined use of natural products with TAM produced synergistic anti-cancer effects, including improved inhibition of tumor cell growth and TAM sensitivity and reduced side effects or toxicity of TAM. In contrast, some natural products, including Angelica sinensis (Oliv.) Diels [Apiaceae] , Paeonia lactiflora Pall, Rehmannia glutinosa (Gaertn.) DC. , Astragalus mongholicus Bunge, and Glycyrrhiza glabra L. [Fabaceae], showed estrogen-like activity, which may reduce the anti-cancer effect of TAM. Some natural products, including morin, silybin, epigallocatechin gallate (EGCG), myricetin, baicalein, curcumin, kaempferol, or quercetin, were found to increase the bioavailability of TAM and its metabolites in vivo . However, three are limited clinical studies on the combination of natural products and TAM. Conclusion: There is evidence for potential interactions of various natural products with TAM in pre-clinical studies, although the relevant clinical evidence is still lacking. Further studies are warranted to evaluate the potential interactions of natural products with TAM in clinical settings.

pharmacology & pharmacy
[Effect of brain calcium and magnesium on anesthetic requirement (MAC) in dogs (author's transl)].

Y. Tanifuji,T. Nezu,K. Kobayashi

1980-08-01

Abstract:
Mandibular reconstruction using implantable stabilization plates.

V. Strelzow

DOI: https://doi.org/10.1001/ARCHOTOL.1983.00800190055014

1983-05-01

A M A Archives of Otolaryngology

Abstract:The consequences of substantial mandibular loss usually are disturbances in mastication and often in cosmesis. In an attempt to arrive at an easy and reliable technique of reconstructing mandibular defects, a selected group of patients were treated using rigid, implantable reconstruction plates. These were used to provide continuity and stability for the residual mandible with or without the use of graft materials. These have included autogenous fresh, irradiated, or frozen bone, and polytetrafluoroethylene carbon fiber sponge (Proplast). A discussion of the principles and technique of using reconstruction plates is outlined.
Role of Natural Products in Tumor Therapy from Basic Research and Clinical Perspectives

Zhisen Wang,Zhengcheng Liu,Jiao Qu,Yang Sun,Wencheng Zhou

DOI: https://doi.org/10.15212/amm-2023-0050

2024-01-01

Acta Materia Medica

Abstract:Cancer is the leading cause of morbidity and mortality worldwide and is an important barrier to lengthening life expectancy in every country. Natural products are receiving increased attention from researchers globally and increasing numbers of natural products are approved for clinical studies involving cancer in recent years. To gain more insight into natural products that have undergone clinical trials for cancer treatment, a comprehensive search was conducted. The https://clinicaltrials.gov website was searched for relevant clinical trials and natural product information up to December 2022. The search terms included different types of cancers, such as colorectal, lung, breast, gynecologic, kidney, bladder, melanoma, pancreatic, hepatocellular, gastric and haematologic. Then, PubMed and Web of Science were searched for relevant articles up to February 2024. Hence, we listed existing clinical trials about natural products used in the treatment of cancers and discussed the preclinical and clinical studies of some promising natural products and their targets, indications, and underlying mechanisms of action. Our intent was to provide basic information to readers who are interested or majoring in natural products and obtain a deeper understanding of the progress and actions of natural product mechanisms of action.
Herb-antitumour drug interaction risks: retrospective integrative oncology study

Noah Samuels,Shir Shapira,Eran Ben-Arye

DOI: https://doi.org/10.1136/spcare-2024-005098

2024-08-13

Abstract:Objectives: The use of herbal medicine is widespread among oncology patients, with potentially negative interactions with anticancer drugs. This study identified herbal products being used among a cohort of oncology patients, assessing the risk for an herb-drug interaction. Methods: Herbal medicine use was examined among 42 oncology patients, identifying potential herb-drug interactions using four online sites. The risk for an interaction was scored using the Working Group on Pharmacotherapy and Drug Information of the Royal Dutch Association for the Advancement of Pharmacy (KNMP). Results: Most patients (62%) reported herbal medicine use, with 70 products identified; 8 herbs and 13 herbal formulas with unidentified components; and 24 anticancer drugs. Herbal medicine use was more prevalent among female patients (p=0.038), with only nine potential herb-drug interactions identified on at least one site. A maximal KNMP Score of 1 (ie, incomplete published case report) was found with only one interaction. Conclusions: The risk for interactions between herbal products and anticancer drugs is difficult to predict, with online search engines providing limited and inconsistent information. Clinical implications of herb-antitumor drug interactions need to be better understood, enabling patients and their oncology healthcare providers to make informed decisions regarding their care.
Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.

Kaichiro Yamamoto,M. Iwahana,E. Kumazawa,K. Kakihata,K. Abe,F. Hirano,A. Tohgo,H. Hoshiai,K. Noda

DOI: https://doi.org/10.3892/OR.10.3.593

2003-05-01

Abstract:Antitumor activity of combination chemotherapy with irinotecan hydrochloride (CPT-11) and nedaplatin was compared to that with CPT-11 and cisplatin. In vitro cytotoxicity of SN-38 (an active metabolite of CPT-11) in combination with nedaplatin or cisplatin was evaluated using three human cervical cancer cell lines (ME-180, CaSki and SiHa). IC50 values of nedaplatin against these three human cervical cancer cell lines were about 2-fold as high as those of cisplatin, indicating somewhat weak cytotoxic effects of nedaplatin. Interactions between two drugs in combination were investigated using a simultaneous-exposure schedule and analyzed by the IC50-based isobologram method. Simultaneous exposure to SN-38 with each platinum preparation showed synergistic and additive effects against ME-180 and SiHa. In vivo antitumor effects of CPT-11 in the combination with each platinum were studied using SiHa xenografts. While CPT-11, nedaplatin and cisplatin alone hardly showed any antitumor effects even at the maximum tolerated dose (MTD) levels, the combination chemotherapy with CPT-11 and nedaplatin or cisplatin resulted in significant antitumor effects even at three-quarter MTD of CPT-11 combined with two-third MTD of platinum. All treatments were tolerable for mice, indicating that the combinations did not cause significant enhancement in toxicity. In clinical application, nedaplatin causes a lower incidence of nephropathy and does not require the replacement of a large volume of fluid, which is needed for cisplatin administration, facilitating treatment at the out-patient clinic. In addition, the incidences of digestive disorder, peripheral neuropathy and auditory disorder are lower. These findings suggest that the combination chemotherapy with CPT-11 and nedaplatin for squamous cell cancer of uterine cervix is very useful in clinical practice. A dose-finding study should be conducted.
Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends

Benjamin Scaria,Siddhartha Sood,Christopher Raad,Jana Khanafer,Rahul Jayachandiran,Alaina Pupulin,Sahibjot Grewal,Michael Okoko,Mansi Arora,Lauren Miles,Siyaram Pandey

DOI: https://doi.org/10.3390/ijms21228480

IF: 5.6

2020-11-11

International Journal of Molecular Sciences

Abstract:Most cancer therapeutics, such as tubulin-targeting chemotherapy drugs, cause cytotoxic, non-selective effects. These harmful side-effects drastically reduce the cancer patient’s quality of life. Recently, researchers have focused their efforts on studying natural health products (NHP’s) which have demonstrated the ability to selectively target cancer cells in cellular and animal models. However, the major hurdle of clinical validation remains. NHP’s warrant further clinical investigation as a therapeutic option since they exhibit low toxicity, while retaining a selective effect. Additionally, they can sensitize cancerous cells to chemotherapy, which enhances the efficacy of chemotherapeutic drugs, indicating that they can be utilized as supplemental therapy. An additional area for further research is the investigation of drug–drug interactions between NHP’s and chemotherapeutics. The objectives of this review are to report the most recent results from the field of anticancer NHP research, and to highlight the most recent advancements in possible supplemental therapeutic options.
Synergistic and Additive Effects of Herbal Medicines in Combination with Chemotherapeutics: A Scoping Review

Taehun Jung,Chunhoo Cheon

DOI: https://doi.org/10.1177/15347354241259416

2024-06-15

Integrative Cancer Therapies

Abstract:Integrative Cancer Therapies, Volume 23, Issue , January-December 2024. Background:Natural products are increasingly gaining interest as potential new drug candidates for cancer treatment. Herbal formula, which are combinations of several herbs, are primarily used in East Asia and have a long history of use that continues today. Recently, research exploring the combination of herbal formulas and chemotherapy for cancer treatment has been on the rise.Methods:This study reviewed research on the co-administration of herbal formulas and chemotherapy for cancer treatment. The databases PubMed, Embase, and Cochrane Library were used for article searches. The following keywords were employed: "Antineoplastic agents," "Chemotherapy," "Phytotherapy," "Herbal medicine," "Drug synergism," and "Synergistic effect." The selection process focused on studies that investigated the synergistic interaction between herbal formulas and chemotherapeutic agents.Results:Among the 30 studies included, 25 herbal formulas and 7 chemotherapies were used. The chemotherapy agents co-administered included cisplatin, 5-fluorouracil, docetaxel, doxorubicin, oxaliplatin, irinotecan, and gemcitabine. The types of cancer most frequently studied were lung, breast, and colon cancers. Most studies evaluating the anticancer efficacy of combined herbal formula and chemotherapy treatment were conducted in vitro or in vivo.Discussion:Most studies reported synergistic effects on cytotoxicity, apoptosis, and tumor growth inhibition. These effects were found to be associated with cell cycle arrest, anti-angiogenesis, and gene expression regulation. Further studies leading to clinical trials are required. Clinical experiences in East Asian countries could provide insights for future research.

oncology,integrative & complementary medicine
Current perspectives in herbal and conventional drug interactions based on clinical manifestations

Ajaykumar Rikhabchand Surana,Shivam Puranmal Agrawal,Manoj Ramesh Kumbhare,Snehal Balu Gaikwad

DOI: https://doi.org/10.1186/s43094-021-00256-w

2021-05-20

Future Journal of Pharmaceutical Sciences

Abstract:Abstract Background Herbs are an important source of pharmaceuticals. Herbs are traditionally used by millions of peoples for medicine, food and drink in developed and developing nations considering that they are safe. But, interaction of herbs with other medicines may cause serious adverse effects or reduces their efficacy. The demand for “alternative” medicines has been increased significantly, which include medicine derived from plant or herbal origin. The objective of this review article mainly focuses on drug interactions of commonly used herbs along with possible mechanisms. The method adopted for this review is searching of herb-drug interactions in online database. Main text Herb-drug interaction leads to pharmacological modification. The drug use along with herbs may show pharmacodynamic and pharmacokinetic interactions. Pharmacokinetic interaction causes alteration in absorption, distribution, metabolism and elimination. Similarly, pharmacodynamic interaction causes additive or synergistic or antagonist effect on the drugs or vice versa. Researchers had demonstrated that herbs show the toxicities and drug interactions like other pharmacologically active compounds. There is lack of knowledge amongst physician, pharmacist and consumers related to pharmacological action and mechanism of herb-drug interaction. This review article focuses on the herb-drug interaction of danshen ( Salvia miltiorrhiza ), Echinacea ( Echinacea purpurea ), garlic ( Allium sativum ), ginkgo ( Ginkgo biloba ), goldenseal ( Hydrastis canadensis ), green tea ( Camellia sinensis ), kava ( Piper methysticum ), liquorice ( Glycyrrhiza glabra ), milk thistle ( Silybum marianum ) and St. John’s wort ( Hypericum perforatum ) along with probable mechanisms and clinical manifestation based on case studies reported in literature. Conclusion Herb-drug interactions may lead to serious side effects. Physician, pharmacist and patients must be more cautious while prescribing and or consuming these herbs.
Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism

Jing Zhang,Yongya Wu,Yanhong Li,Shutong Li,Jiaxi Liu,Xiao Yang,Guiyang Xia,Guan Wang

DOI: https://doi.org/10.1016/j.phymed.2024.155600

IF: 6.656

2024-04-14

Phytomedicine

Abstract:Background Breast cancer stands as the most common malignancy among women globally and a leading cause of cancer-related mortality. Conventional treatments, such as surgery, hormone therapy, radiotherapy, chemotherapy, and small-molecule targeted therapy, often fall short of addressing the complexity and heterogeneity of certain breast cancer subtypes, leading to drug resistance and metastatic progression. Thus, the search for novel therapeutic targets and agents is imperative. Given their low toxicity and abundant variety, natural products and their derivatives are increasingly considered valuable sources for small-molecule anticancer drugs. Purpose This review aims to elucidate the pharmacological impacts and underlying mechanisms of active compounds found in select natural products and their derivatives, primarily focusing on breast cancer treatment. It intends to underscore the potential of these substances in combating breast cancer and guide future research directions for the development of natural product-based therapeutics. Methods We conducted comprehensive searches in electronic databases such as PubMed, Web of Science, and Scopus until October 2023, using keywords such as 'breast cancer', 'natural products', 'derivatives', 'mechanism', 'signaling pathways', and various keyword combinations. Results The review presents a spectrum of phytochemicals, including but not limited to flavonoids, polyphenols, and alkaloids, and examines their actions in various animal and cellular models of breast cancer. The anticancer effects of these natural products and derivatives are manifested through diverse mechanisms, including induction of cell death via apoptosis and autophagy, and suppression of tumor angiogenesis. Conclusion An increasing array of natural products and their derivatives are proving effective against breast cancer. Future therapeutic strategies can benefit from strategic enhancement of the anticancer properties of natural compounds, optimization for targeted action, improved bioavailability, and minimized side effects. The forthcoming research on natural products should prioritize these facets to maximize their therapeutic potential

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective

Raffaele Pezzani,Bahare Salehi,Sara Vitalini,Marcello Iriti,Felipe Andrés Zuñiga,Javad Sharifi-Rad,Miquel Martorell,Natália Martins,Felipe Zuñiga

DOI: https://doi.org/10.3390/medicina55040110

2019-04-17

Medicina

Abstract:Synergy is a process in which some substances cooperate to reach a combined effect that is greater than the sum of their separate effects. It can be considered a natural “straight” strategy which has evolved by nature to obtain more efficacy at low cost. In this regard, synergistic effects may be observed in the interaction between herbal products and conventional drugs or biochemical compounds. It is important to identify and exploit these interactions since any improvement brought by such kind of process can be advantageously used to treat human disorders. Even in a complex disease such as cancer, positive synergistic plant–drug interactions should be investigated to achieve the best outcomes, including providing a greater benefit to patients or avoiding adverse side effects. This review analyzes and summarizes the current knowledge on the synergistic effects of plant–drug interactions with a focus on anticancer strategies.
The Role and Mechanisms of Action of Natural Compounds in the Prevention and Treatment of Cancer and Cancer Metastasis

Yunqiao Wang,Mingtai Chen,Hao Yu,Gang Yuan,Li Luo,Xiongfei Xu,Yanneng Xu,Xinbing Sui,Elaine Lai-Han Leung,Qibiao Wu

DOI: https://doi.org/10.31083/j.fbl2706192

IF: 3.1

2022-06-15

Frontiers in Bioscience-Landmark

Abstract:Cancer has emerged as one of the world's most concerning health problems. The progression and metastasis mechanisms of cancer are complex, including metabolic disorders, oxidative stress, inflammation, apoptosis, and intestinal microflora disorders. These pose significant challenges to our efforts to prevent and treat cancer and its metastasis. Natural drugs have a long history of use in the prevention and treatment of cancer. Many effective anti-tumor drugs, such as Paclitaxel, Vincristine, and Camptothecin, have been widely prescribed for the prevention and treatment of cancer. In recent years, a trend in the field of antitumor drug development has been to screen the active antitumor ingredients from natural drugs and conduct in-depth studies on the mechanisms of their antitumor activity. In this review, high-frequency keywords included in the literature of several common Chinese and English databases were analyzed. The results showed that five Chinese herbal medicines (Radix Salviae, Panax Ginseng C. A. Mey, Hedysarum Multijugum Maxim, Ganoderma, and Curcumaelongae Rhizoma) and three natural compounds (quercetin, luteolin, and kaempferol) were most commonly used for the prevention and treatment of cancer and cancer metastasis. The main mechanisms of action of these active compounds in tumor-related research were summarized. Finally, we found that four natural compounds (dihydrotanshinone, sclareol, isoimperatorin, and girinimbin) have recently attracted the most attention in the field of anti-cancer research. Our findings provide some inspiration for future research on natural compounds against tumors and new insights into the role and mechanisms of natural compounds in the prevention and treatment of cancer and cancer metastasis.

cell biology,biochemistry & molecular biology
Ulysses directives in The Netherlands: opinions of psychiatrists and clients.

I. Varekamp

DOI: https://doi.org/10.1016/J.HEALTHPOL.2004.03.003

IF: 3.255

2004-12-01

Health Policy

Abstract:
Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Hongrui Zhou,Mengxue Zhang,Huihui Cao,Xintong Du,Xin Zhang,Jin Wang,Xiuli Bi

DOI: https://doi.org/10.3390/ph16121734

IF: 4.6

2023-12-16

Pharmaceuticals

Abstract:The application of chemotherapy drugs in tumor treatment has a long history, but the lack of selectivity of drugs often leads to serious side effects during chemotherapy. The natural anti-tumor ingredients derived from Chinese herbal medicine are attracting increased attention due to their diverse anti-tumor effects, abundant resources, and minimal side effects. An effective anti-tumor strategy may lie in the combination of these naturally derived anti-tumor ingredients with conventional chemotherapy drugs. This approach could potentially inhibit tumor growth and the development of drug resistance in tumor cells while reducing the adverse effects of chemotherapy drugs. This review provides a comprehensive overview of the combined therapy strategies integrating natural anti-tumor components from Chinese herbal medicine with chemotherapy drugs in current research. We primarily summarize various compounds in Chinese herbal medicine exhibiting natural anti-tumor activities and the relevant mechanisms in synergistic anti-tumor combination therapy. The focus of this paper is on underlining that this integrative approach, combining natural anti-tumor components of Chinese herbal medicine with chemotherapy drugs, presents a novel cancer treatment methodology, thereby providing new insights for future oncological research.

pharmacology & pharmacy,chemistry, medicinal
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy

Kuzhuvelil B. Harikumar,Yadu Vijayan,Jaskirat Singh Sandhu

DOI: https://doi.org/10.2174/0109298673274796240116105555

IF: 4.74

2024-02-15

Current Medicinal Chemistry

Abstract:Abstract: Immunotherapy is a newly emerging and effective approach to treating cancer. However, there are many challenges associated with using checkpoint inhibitors in this treatment strategy. The component of the tumor microenvironment plays a crucial role in antitumor immune response, regulating tumor immune surveillance as immunological evasion. Natural products/phytochemicals can modulate the tumor microenvironment and function as immunomodulatory agents. In clinical settings, there is a strong need to develop synergistic combination regimens using natural products that can effectively enhance the therapeutic benefits of immune checkpoint inhibitors relative to their effectiveness as single therapies. The review discusses immunotherapy, its side effects, and a summary of evidence suggesting the use of natural products to modulate immune checkpoint pathways.

pharmacology & pharmacy,biochemistry & molecular biology,chemistry, medicinal
Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics

Pamela Ovadje,Alessia Roma,Matthew Steckle,Leah Nicoletti,John Thor Arnason,Siyaram Pandey

DOI: https://doi.org/10.1155/2015/751348

2015-01-01

Abstract:Natural health products (NHPs) are defined as natural extracts containing polychemical mixtures; they play a leading role in the discovery and development of drugs, for disease treatment. More than 50% of current cancer therapeutics are derived from natural sources. However, the efficacy of natural extracts in treating cancer has not been explored extensively. Scientific research into the validity and mechanism of action of these products is needed to develop NHPs as main stream cancer therapy. The preclinical and clinical validation of NHPs would be essential for this development. This review summarizes some of the recent advancements in the area of NHPs with anticancer effects. This review also focuses on various NHPs that have been studied to scientifically validate their claims as anticancer agents. Furthermore, this review emphasizes the efficacy of these NHPs in targeting the multiple vulnerabilities of cancer cells for a more selective efficacious treatment. The studies reviewed here have paved the way for the introduction of more NHPs from traditional medicine to the forefront of modern medicine, in order to provide alternative, safer, and cheaper complementary treatments for cancer therapy and possibly improve the quality of life of cancer patients.

integrative & complementary medicine
Natural products and derivatives in renal, urothelial and testicular cancers: targeting signaling pathways and therapeutic potential

Dengxiong Li,Jie Wang,Zhouting Tuo,Koo Han Yoo,Qingxin Yu,Akira MIYAMOTO,Chi Zhang,Xing Ye,Wuran Wei,Ruicheng Wu,Dechao Feng

DOI: https://doi.org/10.1016/j.phymed.2024.155503

IF: 6.656

2024-03-01

Phytomedicine

Abstract:Background : Natural products have demonstrated significant potential in cancer drug discovery, particularly in renal cancer (RCa), urothelial carcinoma (UC), and testicular cancer (TC). Purpose : This review aims to examine the effects of natural products on RCa, UC and TC. Study design : systematic review Methods : PubMed and Web of Science databases were retrieved to search studies about the effects of natural products and derivatives on these cancers. Relevant publications in the reference list of enrolled studies were also checked. Results : This review highlighted their diverse impacts on key aspects such as cell growth, apoptosis, metastasis, therapy response, and the immune microenvironment. Natural products not only hold promise for novel drug development but also enhance the efficacy of existing chemotherapy and immunotherapy. Importantly, we exert their effects through modulation of critical pathways and target genes, including the PI3K/AKT pathway, NF-κB pathway, STAT pathway and MAPK pathway, among others in RCa, UC, and TC. Conclusion : These mechanistic insights provide valuable guidance for researchers, facilitating the selection of promising natural products for cancer management and offering potential avenues for further gene regulation studies in the context of cancer treatment.

pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences
Herbal Medicines as Adjuncts to Cancer Chemotherapy—Part 2: Non-Immune Support

Claire Zimmerman,Eric Yarnell

DOI: https://doi.org/10.1089/act.2019.29214.eya

2019-04-01

Alternative and Complementary Therapies

Abstract:Part 1 of this article focused on immunomodulating herbal adjuncts to chemotherapy treatment. Part 2 highlights herbal therapies for specific adverse side effects, including nausea, vomiting, anorexia, mucositis, neuropathy, and organ damage. Various herbal formulas are examined, including Liù Jūn Zǐ Tāng (Six Gentlemen Decoction, rikkunshi-tō), Niú Chē Shèn Qì Wán (Life Preserving Kidney Qi Pill, goshajinkigan), Guilongtongluofang, Sháo yào gān cǎo tāng (Peony and Licorice Decoction, shakuyaku-kanzo-tō), and others. Individual herbs examined in depth include Astragalus membranaceus (astragalus), Zingiber officinale (ginger), Cannabis sativa (cannabis), Achillea millefolium (yarrow), Plantago spp. (plantain), Glycyrrhiza spp. (licorice), Matricaria chamomilla (chamomile), Mentha x piperita (peppermint), Rhodiola rosea (rose root), Rhodiola algida (Tibetan rose root), Annona muricata (soursop), Silybum marianum (milk thistle), capsaicin, honey, and Taiwanofungus camphoratus (stout camphor fungus). The findings discussed in this paper present promising results for herbal therapeutic remedies to treat the diverse adverse side effects affecting quality of life associated with cancer treatment effectively.

English Else

THE USE OF LOW MOLECULAR WEIGHT DEXTRAN IN EXTRACORPOREAL CIRCULATION.

Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects

Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review

[Effect of brain calcium and magnesium on anesthetic requirement (MAC) in dogs (author's transl)].

Mandibular reconstruction using implantable stabilization plates.

Role of Natural Products in Tumor Therapy from Basic Research and Clinical Perspectives

Herb-antitumour drug interaction risks: retrospective integrative oncology study

Antitumor activity of new combination chemotherapy with irinotecan hydrochloride and nedaplatin against human cervical cancer cell lines.

Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends

Synergistic and Additive Effects of Herbal Medicines in Combination with Chemotherapeutics: A Scoping Review

Current perspectives in herbal and conventional drug interactions based on clinical manifestations

Natural products and derivatives for breast cancer treatment: From drug discovery to molecular mechanism

Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective

The Role and Mechanisms of Action of Natural Compounds in the Prevention and Treatment of Cancer and Cancer Metastasis

Ulysses directives in The Netherlands: opinions of psychiatrists and clients.

Research Progress on the Synergistic Anti-Tumor Effect of Natural Anti-Tumor Components of Chinese Herbal Medicine Combined with Chemotherapy Drugs

Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy

Advances in the Research and Development of Natural Health Products as Main Stream Cancer Therapeutics

Natural products and derivatives in renal, urothelial and testicular cancers: targeting signaling pathways and therapeutic potential

Herbal Medicines as Adjuncts to Cancer Chemotherapy—Part 2: Non-Immune Support